Welmate Anti Diarrheal Loperamide Hcl Tablet
NDC Package 73581-101-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Welmate Anti Diarrheal Loperamide Hcl (loperamide hydrochloride) tablets is drink plenty of clear fluids to help prevent dehydration caused by diarrheafind right dose on chart. This formulation utilizes a tablet delivery system. Marketed by Yyba Corp, this product is identified by NDC 73581-101 and is authorized under FDA application ANDA076497.

Identification & Billing

NDC Package Code
73581-101-24
Package Description
4 BLISTER PACK in 1 CARTON / 6 TABLET in 1 BLISTER PACK
Product Code
73581-101
11-Digit Billing Format
73581010124
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Welmate Anti Diarrheal Loperamide Hcl
Non-Proprietary Name
Loperamide Hydrochloride
Substance Name
Loperamide Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
LOPERAMIDE HYDROCHLORIDE 2 mg/1
Pharmacologic Class
Usage Information
Drink plenty of clear fluids to help prevent dehydration caused by diarrheafind right dose on chart. If possible, use weight to dose; otherwise, use age. adults and children 12 years and over 2 caplets after the first loose stool; 1 caplet after each subsequent loose stool; but no more than 4 caplets in 24 hours children 9-11 years (60-95 lbs) 1 caplet after the first loose stool; 1/2 caplet after each subsequent loose stool; but no more than 3 caplets in 24 hours children 6-8 years (48-59 lbs) 1 caplet after the first loose stool; 1/2 caplet after each subsequent loose stool; but no more than 2 caplets in 24 hours children 2-5 years (34 to 47 lbs) ask a doctor children under 2 years (up to 33 lbs) do not use

Regulatory & Marketing

Labeler Name
Yyba Corp
Product Type
Human Otc Drug
FDA Application #
ANDA076497
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
08-22-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73581-101-24 identifies a specific commercial package of 4 blister pack in 1 carton / 6 tablet in 1 blister pack of Welmate Anti Diarrheal Loperamide Hcl, a human over the counter drug labeled by Yyba Corp. This tablet is formulated for oral use and contains loperamide hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Yyba Corp on August 22, 2020. The current certification is valid through December 31, 2026.

How is this Yyba Corp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73581010124. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73581-101-24
11-Digit CMS (5-4-2)
73581-0101-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.